COVID-19 Patients Characterization, Biobank, Treatment Response and Outcome Predictor

Università Vita-Salute San Raffaele6,000 enrolled

Overview

Collection and analysis of demographic, clinical, radiographic and laboratory characteristics of CoViD-19 patients to identify predictors of disease severity, mortality and treatment response, and to identify subgroup of patients that might benefit from specific therapeutic interventions

Study Type

OBSERVATIONAL

Enrollment

6,000

Conditions

Coronavirus Infections

Interventions

Observational StudyOTHER

Not required

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Patients admitted to hospital with biological samples positive for SARS-CoV-2 * Patients admitted to hospital with negative test but clinical and radiological characteristics highly suggestive of SARS-CoV-2 disease * Patients discharged from emergency department with biological samples positive for SARS-CoV-2 Exclusion Criteria: * None

Locations (13)

Autoimmunity and Vascular Inflammation Unit, Division of Regenerative Medicine, Stem Cells and Gene Therapy - IRCCS San Raffaele Scientific Institute

Milan, Lombardy, Italy

RECRUITING

Outcomes

Primary Outcomes

Characterize Patients With SARS-Cov-2 Infection and to Create a Biobank to Identify Predictors of Disease Severity, Mortality and Treatment Response

Time frame: Hospital stay (2-3 weeks)

Central Contacts

Giovanni Landoni, Professor

CONTACT

+390226436151 landoni.giovanni@hsr.it

Alberto Zangrillo, Professor

CONTACT

+390226436151 zangrillo.alberto@hsr.it

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.